Ching M. Cheung
University of Salford
12 Papers
Ching M. Cheung is an academic researcher from University of Salford. The author has contributed to research in topics: Kidney disease & Renal function. The author has an hindex of 11, co-authored 12 publications. Previous affiliations of Ching M. Cheung include Manchester Academic Health Science Centre.
Chat about Author
Papers
The unrecognized prevalence of chronic kidney disease in diabetes
Rachel J. Middleton,Robert N. Foley,Janet Hegarty,Ching M. Cheung,Patrick McElduff,J. Martin Gibson,Philip A. Kalra,Donal O'Donoghue,John P. New +8 more
TL;DR: In this paper, the burden of chronic kidney disease (CKD) in patients with diabetes and examine the ability of serum creatinine and albuminuria to detect clinically meaningful CKD compared with estimated glomerular filtration rate.
Measurement of single kidney function using dynamic contrast-enhanced MRI: comparison of two models in human subjects.
TL;DR: Two methods for assessing the single kidney glomerular filtration rate (SK‐GFR) in humans using dynamic contrast‐enhanced (DCE)‐MRI are compared.
138
Epidemiology of renal dysfunction and patient outcome in atherosclerotic renal artery occlusion.
Ching M. Cheung,Julian Wright,Ala’deen E. Shurrab,Hari Mamtora,Robert N. Foley,Donal O'Donoghue,Stephen Waldek,Philip A. Kalra +7 more
TL;DR: Multivariate analysis indicated that low baseline GFR was the chief variable independently associated with increased probability of death or need of dialysis but that renal vascular anatomy had no prognostic impact.
119
Dispelling the myth: the use of renin–angiotensin blockade in atheromatous renovascular disease
Constantina Chrysochou,Robert N. Foley,James F. Young,Kaivan Khavandi,Ching M. Cheung,Philip A. Kalra +5 more
TL;DR: RAB is well tolerated even in patients with bilateral severe RAS and reduced mortality in a large group of ARVD patients, and should be considered an emerging indication for renal revascularization to facilitate their re-introduction.
The benefit of renal artery stenting in patients with atheromatous renovascular disease and advanced chronic kidney disease.
Philip A. Kalra,Constantina Chrysochou,Darren Green,Ching M. Cheung,Kaivan Khavandi,Sebastian Sixt,Aljoscha Rastan,Thomas Zeller +7 more
TL;DR: It is shown that percutaneous renal revascularization can improve renal function in advanced CKD (stages 4–5) and that this can provide a survival advantage in prospective analysis.
98